We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$819M
AUM Growth
+$123M
(+18%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
9.75%
Holding
710
New
168
Increased
162
Reduced
95
Closed
285
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$9.74M |
| 2 |
McDonald's
MCD
|
+$8.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$8.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$7.37M |
| 5 |
Henry Schein
HSIC
|
+$6.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$7.17M |
| 2 |
Lam Research
LRCX
|
+$6.99M |
| 3 |
Electronic Arts
EA
|
+$6.98M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$6.79M |
| 5 |
Hilton Worldwide
HLT
|
+$6.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.19% |
| 2 | Technology | 15.05% |
| 3 | Consumer Discretionary | 14.44% |
| 4 | Financials | 11.43% |
| 5 | Consumer Staples | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Hubbell
HUBB
$25.6B
| $1.88M | 0.23% |
16,200
+13,000
| +406% | +$1.49M |
|
|
WR
152
DELISTED
Westar Energy Inc
WR
| $1.88M | 0.23% |
37,900
-7,400
| -16% | -$376K |
|
|
APC
153
DELISTED
Anadarko Petroleum
APC
| $1.83M | 0.22% |
37,555
-116,800
| -76% | -$5.15M |
|
154
Cognex
CGNX
$10B
| $1.83M | 0.22% |
33,200
-18,400
| -36% | -$934K |
|
|
MDRX
155
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.81M | 0.22% |
+127,200
| New | +$1.65M |
|
|
FIT
156
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.76M | 0.21% |
252,925
-7,553
| -3% | -$44K |
|
157
Copart
CPRT
$28.4B
| $1.76M | 0.21% |
+204,400
| New | +$1.64M |
|
|
FOLD
158
DELISTED
Amicus Therapeutics
FOLD
| $1.75M | 0.21% |
115,700
+114,900
| +14,363% | +$1.52M |
|
159
Lincoln National
LNC
$8.19B
| $1.73M | 0.21% |
23,600
+14,200
| +151% | +$1M |
|
|
BLUE
160
DELISTED
bluebird bio
BLUE
| $1.72M | 0.21% |
+966
| New | +$1.35M |
|
161
Element Solutions
ESI
$8.89B
| $1.72M | 0.21% |
+154,100
| New | +$1.91M |
|
162
Enovis
ENOV
$1.7B
| $1.7M | 0.21% |
23,763
+2,034
| +9% | +$142K |
|
|
OPLN
163
Openlane
OPLN
$4.27B
| $1.64M | 0.2% |
90,621
-36,195
| -29% | -$597K |
|
164
Golar LNG
GLNG
$4.95B
| $1.63M | 0.2% |
72,170
+63,300
| +714% | +$1.39M |
|
165
Taylor Morrison
TMHC
| $1.63M | 0.2% |
74,000
+29,200
| +65% | +$645K |
|
166
Lennar Class A
LEN
$21.1B
| $1.62M | 0.2% |
32,260
-35,509
| -52% | -$1.77M |
|
|
RICE
167
DELISTED
Rice Energy Inc.
RICE
| $1.61M | 0.2% |
55,729
+51,300
| +1,158% | +$1.4M |
|
168
Thor Industries
THO
$4.13B
| $1.61M | 0.2% |
12,800
-27,500
| -68% | -$2.97M |
|
169
Popular Inc
BPOP
$11.1B
| $1.61M | 0.2% |
+44,800
| New | +$1.81M |
|
|
ILG
170
DELISTED
ILG, Inc Common Stock
ILG
| $1.6M | 0.2% |
59,900
-400
| -0.7% | -$10.6K |
|
171
Live Nation Entertainment
LYV
$42.1B
| $1.6M | 0.2% |
+36,700
| New | +$1.42M |
|
172
Broadcom
AVGO
$1.81T
| $1.58M | 0.19% |
65,000
+35,000
| +117% | +$865K |
|
173
Jefferies Financial Group
JEF
$13.2B
| $1.57M | 0.19% |
+69,701
| New | +$1.56M |
|
174
Lazard
LAZ
$4.21B
| $1.57M | 0.19% |
34,800
+13,900
| +67% | +$616K |
|
175
Bankunited
BKU
$3.41B
| $1.56M | 0.19% |
43,900
+39,500
| +898% | +$1.33M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Seven Eight Capital held 710 positions worth $819M, up 18% from $696M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $101M of net new capital in Q3 2017, opening 168 new positions and adding to 162 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Constellation Brands, an estimated $6.37M trimmed.
- Seven Eight Capital's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
- Seven Eight Capital added most to McDonald's in Q3 2017, an estimated $8.2M increase.
- Seven Eight Capital's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $6.37M.
- Seven Eight Capital fully exited Nike in Q3 2017, selling an estimated $7.17M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $819M portfolio in Q3 2017.
- Seven Eight Capital opened 168 new positions and closed 285 in Q3 2017.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Seven Eight Capital's 13F filing for Q3 2017, filed 16 Oct 2017.